SueWallSt
This episode dives into Medpace Holdings $MEDP and a high stakes securities case where strong guidance and “well behaved” cancellations collided with a disappointing book to bill miss. Built for investors, traders, and biotech service watchers, we break down CRO trends, backlog risk, cancellations, and revenue visibility. Expect deep dive analysis, financial storytelling, and insights into clinical research stocks and volatility. Visit ZLK.com [https://zlk.com] for more info. Add our WhatsApp Channel [https://whatsapp.com/channel/0029Vb6Nxxj4o7qGr3xmA32v]. We’re not lawyers or accountants, so don’t take this as legal or financial advice.
100 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y forma parte de la comunidad de SueWallSt!